John C. Bolger - 31 May 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Director
Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
31 May 2022
Net transactions value
-$59,244
Form type
4
Filing time
02 Jun 2022, 16:02:25 UTC
Previous filing
20 May 2022
Next filing
03 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Options Exercise $1,229 +313 +7.8% $3.92* 4,313 31 May 2022 Direct
transaction FLGT Common Stock Sale $17,315 -313 -7.3% $55.32 4,000 31 May 2022 Direct
transaction FLGT Common Stock Options Exercise $1,818 +313 +7.8% $5.81* 4,313 31 May 2022 Direct
transaction FLGT Common Stock Sale $17,351 -313 -7.3% $55.44 4,000 31 May 2022 Direct
transaction FLGT Common Stock Sale $27,625 -500 -12% $55.25 3,500 31 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -313 -100% $0.000000* 0 31 May 2022 Common Stock 313 $3.92 Direct F1
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -313 -20% $0.000000 1,250 31 May 2022 Common Stock 313 $5.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.
F2 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.